Laboratory organisation and management of SARS-CoV-2 infection in Niger, West Africa

• Main Authors: Abdourahamane Yacouba, Adamou Lagaré, Daouada Alhousseini Maiga, Halimatou Moumouni Sambo, Sani Ousmane, Zelika Hamidou Harouna, Boubacar Marou, Maman K. Sanoussi, Balki Aoula, Ali Amadou, Hassane Boureima, Saidou Amatagas, Abdoulaye Ousmane, Eric Adehossi, Saidou Mamadou
• Format: Article
• Language: English
• Published: AOSIS 2020-12-01
• Series: African Journal of Laboratory Medicine
• Subjects: severe acute respiratory syndrome coronavirus-2; sars-cov-2; coronavirus disease 2019; covid-19; laboratory diagnosis; west africa; niger
• Online Access: https://ajlmonline.org/index.php/ajlm/article/view/1308

Background: As the coronavirus disease 2019 (COVID-19) pandemic unfolds, laboratory services have been identified as key to its containment. This article outlines the laboratory organisation and management and control interventions in Niger. Intervention: The capitol city of Niger, Niamey, adopted a ‘National COVID-19 Emergency Preparedness and Response Plan’ to strengthen the preparedness of the country for the detection of severe acute respiratory syndrome coronavirus-2. Laboratory training and diagnostic capacity building were supported by existing active clinical and research laboratories for more rapid and practicable responses. The National Reference Laboratory for Respiratory Viruses located at the Centre de Recherche Médicale et Sanitaire was designated as the reference centre for COVID-19 testing. The national plan for COVID-19 testing is being gradually adopted in other regions of the country in response to the rapidly evolving COVID-19 emergency and to ensure a more rapid turn-around time. Lessons learnt: After the decentralisation of COVID-19 testing to other regions of the country, turn-around times were reduced from 48–72 h to 12–24 h. Reducing turn-around times allowed Niger to reduce the length of patients’ stays in hospitals and isolation facilities. Shortages in testing capacity must be anticipated and addressed. In an effort to reduce risk of shortages and increase availability of reagents and consumables, Niamey diversified real-time reverse transcriptase–polymerase chain reaction kits for severe acute respiratory syndrome coronavirus-2 detection. Recommendations: Continued investment in training programmes and laboratory strategy is needed in order to strengthen Niger’s laboratory capacity against the outbreak.